Boston Scientific’s $664m bet on Bolt Medical has paid off, as the company’s intravascular lithotripsy (IVL) system gains US Food and Drug Administration (FDA) clearance. Whilst neither Bolt Medical ...

Boston Scientific stock popped Wednesday after the medtech giant agreed to fully acquire Bolt Medical for up to $900 million. Please watch the video at Investors.com - How To Buy Stocks ...

Boston Scientific announced via social media that it has closed the acquisition of Bolt Medical, which recently gained FDA ...

Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...

Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular lithotripsy (IVL) system, positioning ...

Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target Needham’s latest electrophysiologist survey shows the ...

Recent acquisitions are also seen as adding to Boston Scientific’s growth story. Bolt Medical’s new device for treating ...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and ...

Truist lowered the firm’s price target on Boston Scientific (BSX) to $113 from $120 and keeps a Buy rating on the shares as part of a broad ...

Boston Scientific’s $664m bet on Bolt Medical has paid off, as the company’s intravascular lithotripsy (IVL) system gains US Food and Drug Administration (FDA) clearance. Whilst neither Bolt ...